Suppression of lymphokine-activated killer induction by neutrophils

H Y Shau1, A Kim

  • 1Armand Hammer Laboratory, John Wayne Cancer Clinic, Los Angeles, CA.

Insights

Peripheral blood polymorphonuclear neutrophils (PMN) inhibit lymphokine-activated killer (LAK) cell function in vitro. This suppression is mediated by superoxide anions and suggests a role for PMN in interleukin-2 (IL-2) immunotherapy outcomes.

Area of Science:

  • Immunology
  • Cellular Biology

Background:

  • Interleukin-2 (IL-2) therapy enhances lymphokine-activated killer (LAK) cell activity for cancer treatment.
  • The role of polymorphonuclear neutrophils (PMN) in modulating LAK cell function is not fully understood.

Purpose of the Study:

  • To investigate the effect of peripheral blood polymorphonuclear neutrophils (PMN) on the induction of LAK cell function by IL-2 in vitro.
  • To elucidate the mechanism by which PMN suppress LAK cell induction.

Main Methods:

  • Co-culture of peripheral blood lymphocytes (PBL) with varying concentrations of intact PMN in the presence of recombinant IL-2 (rIL-2).
  • Assessment of LAK cell function and analysis of suppressive mechanisms, including the role of reactive oxygen species and cell contact.
  • Treatment with superoxide dismutase (SOD) and catalase to identify the suppressive factor.

Main Results:

  • PMN significantly suppressed IL-2-induced LAK cell function in a dose-dependent manner.
  • Suppression required intact PMN but not direct cell-to-cell contact or prior activation with immunoregulators.
  • The suppressive effect was reversed by SOD, indicating involvement of superoxide anion, but not by catalase.
  • PMN did not inhibit IL-2 utilization or deplete LAK precursor cells.

Conclusions:

  • Peripheral blood PMN possess a potent inhibitory effect on LAK cell induction by IL-2 in vitro.
  • Superoxide anion production by PMN is the likely mediator of this suppression.
  • These findings suggest that PMN may influence the efficacy of IL-2-based immunotherapy in vivo.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...